Skip to main content
. Author manuscript; available in PMC: 2014 May 20.
Published in final edited form as: Stat Med. 2012 Sep 13;32(11):1865–1876. doi: 10.1002/sim.5601

Figure 1. Net benefit against plotted against threshold probabilityfor molecular markers of prostate cancer.

Figure 1

Grey line: biopsy all men. Thick black line: biopsy no men. Thin black line: biopsy if FT test positive. Dashed line: biopsy if HK test positive. The optimal strategy is to biopsy all men if the threshold probability is below 10%; biopsy on the basis of FT is threshold probability is 10 – 25%; biopsy by HK if threshold probability is 25 – 45% and biopsy no man if threshold probability is greater than 45%.